Recombinant Human CX37 Protein，His

CX37, or connexin 37, is a member of the connexin family of proteins that form gap junctions, facilitating direct intercellular communication. Research on CX37 has gained significant attention due to its role in various physiological processes and its potential implications in disease pathogenesis, particularly in cardiovascular and cancer biology. It is predominantly expressed in vascular endothelial cells, where it plays a crucial role in maintaining endothelial function, regulating vascular permeability, and influencing angiogenesis. Studies have demonstrated that alterations in CX37 expression or function can contribute to endothelial dysfunction and have been associated with conditions such as atherosclerosis and hypertension. Moreover, CX37's involvement in tumor biology has become an emerging area of interest, as its dysregulation may affect cell proliferation, migration, and apoptosis in cancer cells. The development of recombinant CX37 proteins provides a valuable tool for further elucidating its biological functions and therapeutic potentials. By exploring the structural and functional properties of CX37 through recombinant approaches, researchers aim to understand how it interacts with other cellular components and its mechanistic pathways in both normal and pathological contexts. This knowledge is crucial for identifying potential therapeutic targets for diseases where CX37 is implicated. Thus, the investigation of CX37 recombinant proteins is not only essential for basic scientific understanding but also holds promise for translational research in developing novel interventions for cardiovascular diseases and cancer.